
#### NACHC.A1 HIV Infection Conditions

|Data Element Id|Data Element|
|---|---|
|NACHC.A1.DE1|[HIV infection as a condition](StructureDefinition-nachc-a1-de1.html)|

#### NACHC.A2 HIV test

|Data Element Id|Data Element|
|---|---|
|NACHC.A2.DE1|[HIV-1 HIV 2 Ab Ag tests](StructureDefinition-nachc-a2-de1.html)|
|NACHC.A2.DE2|[HIV Viral Load](StructureDefinition-nachc-a2-de2.html)|

#### NACHC.B1 HCV

|Data Element Id|Data Element|
|---|---|
|NACHC.B1.DE1|[Hepatitis C Virus Infection (Disorders)](StructureDefinition-nachc-b1-de1.html)|
|NACHC.B1.DE2|[Chronic Infection of liver due to Hepatitis C virus.](StructureDefinition-nachc-b1-de2.html)|
|NACHC.B1.DE3|[HCV Infection (Organism or Substance in Lab Results)](StructureDefinition-nachc-b1-de3.html)|
|NACHC.B1.DE4|[Hepatitis C condition](StructureDefinition-nachc-b1-de4.html)|

#### NACHC.B2 HCV test

|Data Element Id|Data Element|
|---|---|
|NACHC.B2.DE1|[Hepatitis C Ag](StructureDefinition-nachc-b2-de1.html)|
|NACHC.B2.DE2|[Hepatitis C nucleic acid](StructureDefinition-nachc-b2-de2.html)|
|NACHC.B2.DE3|[Hepatitis C virus antibody test using Immunoblotting (IB) method.](StructureDefinition-nachc-b2-de3.html)|
|NACHC.B2.DE4|[Hepatitis C virus antibody test.](StructureDefinition-nachc-b2-de4.html)|
|NACHC.B2.DE5|[Hepatitis C virus nucleic (RNA) test.](StructureDefinition-nachc-b2-de5.html)|

#### NACHC.C1 Syphilis

|Data Element Id|Data Element|
|---|---|
|NACHC.C1.DE1|[Syphilis](StructureDefinition-nachc-c1-de1.html)|
|NACHC.C1.DE2|[Syphilis (Organism or Substance in Lab Results)](StructureDefinition-nachc-c1-de2.html)|
|NACHC.C1.DE3|[Syphilis condition](StructureDefinition-nachc-c1-de3.html)|

#### NACHC.C2 Syphilis test

|Data Element Id|Data Element|
|---|---|
|NACHC.C2.DE1|[Syphilis (Tests for Treponema pallidum Nucleic Acid)](StructureDefinition-nachc-c2-de1.html)|
|NACHC.C2.DE2|[Syphilis (Tests for Treponemal or Non Treponemal Antibody)](StructureDefinition-nachc-c2-de2.html)|

#### NACHC.D1 Gonorrhea

|Data Element Id|Data Element|
|---|---|
|NACHC.D1.DE1|[Gonococcal Infections and Venereal Diseases](StructureDefinition-nachc-d1-de1.html)|
|NACHC.D1.DE2|[Gonorrhea [Neisseria gonorrhoeae] (Organism or Substance in Lab Results)](StructureDefinition-nachc-d1-de2.html)|
|NACHC.D1.DE3|[Gonorrhea [Neisseria species Unspecified] (Organism or Substance in Lab Results)](StructureDefinition-nachc-d1-de3.html)|
|NACHC.D1.DE4|[Gonorrhea [Secondary Sites Complications Chronic] (Disorders)](StructureDefinition-nachc-d1-de4.html)|

#### NACHC.D2 Gonorrhea test

|Data Element Id|Data Element|
|---|---|
|NACHC.D2.DE1|[Gonorrhea Tests for Neisseria gonorrhea by Culture](StructureDefinition-nachc-d2-de1.html)|
|NACHC.D2.DE2|[Gonorrhea (Tests for Neisseria gonorrhoeae Nucleic Acid)](StructureDefinition-nachc-d2-de2.html)|
|NACHC.D2.DE3|[Gonorrhea (Tests for Neisseria species by Culture and Identification Method)](StructureDefinition-nachc-d2-de3.html)|
|NACHC.D2.DE4|[Gonorrhea test](StructureDefinition-nachc-d2-de4.html)|
|NACHC.D2.DE5|[Gonorrhea Tests and Chlamydia/Gonorrhea Combined Tests](StructureDefinition-nachc-d2-de5.html)|

#### NACHC.E1 Chlamydia

|Data Element Id|Data Element|
|---|---|
|NACHC.E1.DE1|[Chlamydia](StructureDefinition-nachc-e1-de1.html)|
|NACHC.E1.DE2|[Chlamydia Infections and Venereal Diseases](StructureDefinition-nachc-e1-de2.html)|
|NACHC.E1.DE3|[Chlamydia trachomatis Infection [Secondary Sites Complications] (Disorders)](StructureDefinition-nachc-e1-de3.html)|
|NACHC.E1.DE4|[Chlamydia trachomatis organism or Chlamydia trachomatis substance](StructureDefinition-nachc-e1-de4.html)|

#### NACHC.E2 Chlamydia test

|Data Element Id|Data Element|
|---|---|
|NACHC.E2.DE1|[Chlamydia Screening](StructureDefinition-nachc-e2-de1.html)|
|NACHC.E2.DE2|[Chlamydia test](StructureDefinition-nachc-e2-de2.html)|
|NACHC.E2.DE3|[Chlamydia Trachomatis Tests, FPAR](StructureDefinition-nachc-e2-de3.html)|
|NACHC.E2.DE4|[Tests for Chlamydia trachomatis Antigen](StructureDefinition-nachc-e2-de4.html)|
|NACHC.E2.DE5|[Tests for Chlamydia trachomatis by Culture and Identification Method)](StructureDefinition-nachc-e2-de5.html)|
|NACHC.E2.DE6|[Tests for Chlamydia trachomatis Nucleic Acid](StructureDefinition-nachc-e2-de6.html)|

#### NACHC.F1 Injection Drug Use

|Data Element Id|Data Element|
|---|---|
|NACHC.F1.DE1|[Drug Rehabilitation](StructureDefinition-nachc-f1-de1.html)|
|NACHC.F1.DE2|[Injection Findings](StructureDefinition-nachc-f1-de2.html)|
|NACHC.F1.DE3|[IDU as a condition](StructureDefinition-nachc-f1-de3.html)|
|NACHC.F1.DE4|[Injection Drug Use](StructureDefinition-nachc-f1-de4.html)|

#### NACHC.F2 Pregnancy

|Data Element Id|Data Element|
|---|---|
|NACHC.F2.DE1|[Pregnancy Encounters](StructureDefinition-nachc-f2-de1.html)|
|NACHC.F2.DE2|[Pregnancy Supervision](StructureDefinition-nachc-f2-de2.html)|
|NACHC.F2.DE3|[Maternal Care](StructureDefinition-nachc-f2-de3.html)|
|NACHC.F2.DE4|[Pregnancy Procedures](StructureDefinition-nachc-f2-de4.html)|
|NACHC.F2.DE5|[Pregnancy Observations](StructureDefinition-nachc-f2-de5.html)|
|NACHC.F2.DE6|[Pregnancy Conditions](StructureDefinition-nachc-f2-de6.html)|

#### NACHC.F3 Post Exposure Prophylaxis

|Data Element Id|Data Element|
|---|---|
|NACHC.F3.DE1|[Post Exposure Prophylaxis](StructureDefinition-nachc-f3-de1.html)|
